Vinge advises Cantargia AB (publ) in connection with a directed share issue of approximately SEK 59 million to a number of Swedish and international investors.
On 27 October 2023, Norvik hf announced, through the wholly-owned subsidiary Kivron AB, a public takeover offer to the shareholders of Bergs Timber AB (publ) to acquire all shares in Bergs Timber.
Vinge has advised Carnegie Investment Bank AB in connection with the acquisition of the business sectors Erik Penser Wealth Management and Erik Penser Corporate Finance as well as the analytical services Penser Access and Penser Future from Erik Penser Bank AB. The consideration for the completed purchase consists of shares in Carnegie and the acquisition is subject to customary conditions from public authorities.
Vinge has advised Sileon AB (publ) in connection with its rights issue, which provides the company with proceeds of approximately SEK 33.8 million before deduction of transaction costs.
Vinge has advised the Norwegian private equity firm Equip Capital and its portfolio company Remagruppen in connection with the acquisition of Beredningsbart Syd AB (”BNB Syd”).
Vinge advises Fairpoint Capital and eEquity in connection with their investment by participation in a MSEK 90 investment round in Mediatool, a company who provides a digital marketing management platform for brands and media agencies.
Vinge has advised Thermo Fisher Scientific Inc., (”Thermo Fisher”), the world leader in serving science, with annual revenue over $40 billion, in connection with its acquisition of Olink Holding AB (publ) (“Olink”).
Vinge has advised atNorth AB, a leading Nordic data center services company that offers responsible, power-efficient, cost-optimized data center hosting facilities and high-performance computing services, in connection with its acquisition of Gompute and its Spanish subsidiary.
Vinge is advising Studentbostäder i Norden AB (publ), a real estate company whose shares are listed on Nasdaq First North Premier Growth Market, in connection with a fully guaranteed rights issue amounting to a total of SEK 331 million before deduction of transaction costs and the amendments to the terms and conditions of the company’s outstanding green 2021/2024 notes with ISIN SE0015960802 (the “Notes”) by way of a written procedure.
Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment, listed on Nasdaq Stockholm, in connection with a combined financing comprising a SEK 172 million equity private placement and a SEK 290 million debt financing.
MBR is based in Stockholm and carries out all types of ground installations, specialising in reparation and establishment of district heating pipes. The company has 15 employees and a yearly turnover of approximately SEK 60 million.
